Artivion is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. Co. has the following product families: aortic stents and stent grafts, surgical sealants, On-X® mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stents and stent grafts include JOTEC® stent grafts and surgical products, the Ascyrus Medical Dissection Stent hybrid prosthesis, and the NEXUS® endovascular stent graft system. Surgical sealants include BioGlue® Surgical Adhesive products. We show 44 historical shares outstanding datapoints in our CRY shares outstanding history coverage, used to compute CRY market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing CRY market cap history over the course of time is important for investors
interested in comparing CRY's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of CRY versus a peer is one thing; comparing
CRY market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like CRY can fluctuate over the course of history.
With this page we aim to empower investors researching CRY by allowing them to research the CRY market cap history. |
Free CRY Email Alerts:
Video: The Importance of Market Cap
